Records containing: Moderate to Severe Asthma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
-
CLINICAL_TRIALS study record update · 2026-02-11A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of RC1416 Injection in Adult Patients With Moderate to Severe Asthma
-
CLINICAL_TRIALS study record update · 2026-01-30A Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Preliminary Efficacy of RC1416 Injection in Patients With Moderate to Severe Asthma
-
CLINICAL_TRIALS study record update · 2026-01-28A Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Clinical Study of Evaluating the Efficacy and Safety of CM326 in Subjects With Moderate to Severe Asthma
-
CLINICAL_TRIALS study record update · 2026-01-16CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-04Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
-
CLINICAL_TRIALS study record update · 2024-08-19Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
-
CLINICAL_TRIALS study record update · 2023-12-15A Randomized, Double-Blind, Placebo-Controlled Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CM326 in Subjects With Moderate to Severe Asthma
-
CLINICAL_TRIALS study record update · 2023-12-15A Randomized, Double-Blind, Placebo-Controlled Phase Ⅱ/Ⅲ Clinical Study to Evaluate the Efficacy and Safety of CM310 Recombinant Humanized Monoclonal Antibody Injection in Subjects With Moderate to Severe Asthma
-
CLINICAL_TRIALS study record update · 2023-04-21A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Adolescent and Young Adult Participants With Moderate to Severe Asthma (VECTOR)
-
CLINICAL_TRIALS study record update · 2021-02-21A Phase I Randomised Double-Blind Placebo-Controlled Study of Multiple Ascending Dose of KBL693 in Healthy Participants